Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Nasopharyngeal Carcinoma 1Myasthenia Gravis 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Hepatitis 1Esophageal Stenosis 1Esophageal Neoplasms 1Chemical and Drug Induced Liver Injury 1Brain Injuries 1

Interventions

Ursodeoxycholic Acid 1Steroids 1Spermine Synthase 1Prednisone 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Liquid Biopsy 1Clinical Protocols 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hepatitis × Steroids × Clear all
NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown
60 enrolled

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡